Oral Anticancer Therapy: Management of Drug Interactions
- PMID: 30763198
- DOI: 10.1200/JOP.18.00483
Oral Anticancer Therapy: Management of Drug Interactions
Abstract
Oral anticancer therapy is increasingly integrated into the care of patients with cancer. Recognition and management of drug-drug interactions (DDIs) is critical to providing efficacious and safe anticancer treatment. DDIs with QTc-prolonging agents, anticoagulants, enzyme inducers and inhibitors, antidepressants, and acid suppressants are commonly encountered with anticancer therapies. Here, we review frequently observed DDIs and outline literature-supported suggestions for their management.
Comment in
-
Managing Drug Interactions With Oral Anticancer Agents: Signals, Noise, and Echoes.J Oncol Pract. 2019 Feb;15(2):91-92. doi: 10.1200/JOP.18.00721. J Oncol Pract. 2019. PMID: 30763201 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
